A team of researchers who analyzed rates of do-not-resuscitate (DNR) orders in California are suggesting DNR mortality numbers should be taken into account when calculating hospital risk-adjusted heart failure mortality metrics.

Medicare paid at least $1.5 billion over a decade to replace seven types of faulty heart devices, according to a HHS Office of Inspector General report released Oct. 2.

In its first-ever scientific statement on the subject, the American Heart Association said meditation could be a useful treatment tool for cardiac patients, but the organization was careful not to recommend the practice over traditional medical recommendations.

Just over 30 percent of patients who receive a pricey prescription for the cholesterol-lowering medications known as PCSK9 inhibitors (PCSK9i) are able to pay for the drugs, new research states.

A study of antibiotic delivery methods in France revealed an important finding that could be applied to other pharmaceuticals around the world: patients receiving a per-unit dispensing of pills demonstrated greater adherence to the medication than those receiving prepackaged boxes.

A collection of third-party insurance payers has filed a class-action lawsuit seeking $9.9 million from St. Jude Medical and parent company Abbott Laboratories, claiming St. Jude knew about a battery defect in its cardiac defibrillators nearly five years before issuing a recall.

Researchers who surveilled of a handful of “Green Carts” in lower-income regions of New York are suggesting increased access to fresh produce—and the ability to pay for those fruits and vegetables with food stamps—could have a positive effect on overall health in disadvantaged areas.

Recent research from PLOS One estimates half of all stents could be unnecessary. No matter how aware and vigilant cardiologists—and, of course all physicians—are in the face of overtreatment, that single statistic is alarming.